Citadel Advisors
EOLS icon

Citadel Advisors’s Evolus EOLS Stock Holding History

Citadel Advisors’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.8K Sell
12,800
-27,600
-68% -$163K ﹤0.01% 12777
2026
Q1 		$166K Buy
40,400
+27,600
+216% +$134K ﹤0.01% 11598
2025
Q4 		$85.1K Sell
12,800
-20,300
-61% -$138K ﹤0.01% 11752
2025
Q3 		$203K Sell
33,100
-15,300
-32% -$119K ﹤0.01% 11231
2025
Q2 		$446K Buy
48,400
+40,000
+476% +$409K ﹤0.01% 8910
2025
Q1 		$101K Buy
8,400
+5,900
+236% +$77.2K ﹤0.01% 11446
2024
Q4 		$27.6K Buy
2,500
+1,500
+150% +$21.1K ﹤0.01% 12946
2024
Q3 		$16.2K Sell
1,000
-12,700
-93% -$178K ﹤0.01% 12936
2024
Q2 		$149K Buy
13,700
+4,400
+47% +$54.1K ﹤0.01% 10364
2024
Q1 		$130K Buy
9,300
+2,300
+33% +$29.9K ﹤0.01% 10973
2023
Q4 		$73.7K Sell
7,000
-7,100
-50% -$63.5K ﹤0.01% 11325
2023
Q3 		$129K Buy
14,100
+6,800
+93% +$61K ﹤0.01% 10573
2023
Q2 		$53.1K Buy
7,300
+2,900
+66% +$25K ﹤0.01% 11729
2023
Q1 		$37.2K Sell
4,400
-6,500
-60% -$58.8K ﹤0.01% 12511
2022
Q4 		$81.9K Buy
+10,900
New +$84.4K ﹤0.01% 11499
2022
Q3 		– Sell
-10,000
Closed -$116K – 12865
2022
Q2 		$116K Buy
+10,000
New +$118K ﹤0.01% 11258
2022
Q1 		– Sell
-41,800
Closed -$272K – 13822
2021
Q4 		$272K Sell
41,800
-10,200
-20% -$70K ﹤0.01% 11126
2021
Q3 		$396K Sell
52,000
-24,900
-32% -$258K ﹤0.01% 10433
2021
Q2 		$973K Buy
76,900
+25,600
+50% +$282K ﹤0.01% 8435
2021
Q1 		$666K Sell
51,300
-25,600
-33% -$236K ﹤0.01% 9050
2020
Q4 		$258K Buy
76,900
+6,300
+9% +$23.7K ﹤0.01% 9334
2020
Q3 		$276K Buy
70,600
+41,700
+144% +$152K ﹤0.01% 8266
2020
Q2 		$153K Sell
28,900
-13,500
-32% -$62.2K ﹤0.01% 8730
2020
Q1 		$176K Sell
42,400
-42,100
-50% -$357K ﹤0.01% 8138
2019
Q4 		$1.03M Buy
84,500
+37,400
+79% +$527K ﹤0.01% 5526
2019
Q3 		$736K Buy
47,100
+400
+0.9% +$6.55K ﹤0.01% 6107
2019
Q2 		$683K Sell
46,700
-2,300
-5% -$45.6K ﹤0.01% 6313
2019
Q1 		$1.11M Buy
+49,000
New +$1.06M ﹤0.01% 5406

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Citadel Advisors's EOLS Position: Q2 2026 in Review

Citadel Advisors reduced its Evolus (EOLS) stake by 27% in Q2 2026, selling an estimated $1.12M and leaving 506,354 shares worth $3.51M. The position accounts for ﹤0.01% of the portfolio, ranked #5375.

Citadel Advisors first reported a position in EOLS in Q1 2018 and has held it in 30 quarters since. The position peaked at $10.5M in Q4 2019. 159 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Citadel Advisors held 506,354 shares of Evolus worth $3.51M as of Q2 2026.
  • Citadel Advisors sold 190,275 Evolus shares in Q2 2026, an estimated $1.12M.
  • Evolus made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5375 holding.
  • Citadel Advisors first reported a position in Evolus in Q1 2018 and has held it in 30 quarters since.
  • Citadel Advisors's Evolus position peaked at $10.5M in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.